The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy.

Por Anna Maria Nurmi, Jaana Hagström, Harri Mustonen, Hanna Seppänen, Caj Haglund
Publicado em 2022-01-01

The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy

Por Anna Maria Nurmi, Jaana Hagström, Harri Mustonen, Hanna Seppänen, Caj Haglund
Publicado em 2022-01-01

Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.

Por Matilda Holm, Mayank Saraswat, Sakari Joenväärä, Ari Ristimäki, Caj Haglund, Risto Renkonen
Publicado em 2018-01-01

Endoscopic sphincterotomy and risk of cholangiocarcinoma: a population-based cohort study in Finland and Sweden

Por Cecilia Strömberg, Camilla Böckelman, Huan Song, Weimin Ye, Eero Pukkala, Caj Haglund, Magnus Nilsson
Publicado em 2016-09-01

Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma

Por Miia Ruuskanen, Ilmo Leivo, Heikki Minn, Tero Vahlberg, Caj Haglund, Jaana Hagström, Heikki Irjala
Publicado em 2019-06-01

Somatostatin receptor expression in parathyroid neoplasms

Por Sara Storvall, Helena Leijon, Eeva Ryhänen, Johanna Louhimo, Caj Haglund, Camilla Schalin-Jäntti, Johanna Arola
Publicado em 2019-08-01

L1TD1 - a prognostic marker for colon cancer

Por Deepankar Chakroborty, Maheswara Reddy Emani, Riku Klén, Camilla Böckelman, Jaana Hagström, Caj Haglund, Ari Ristimäki, Riitta Lahesmaa, Laura L. Elo
Publicado em 2019-07-01

MAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E‐mutant colorectal adenocarcinoma

Por Kati Räsänen, Kien X. Dang, Harri Mustonen, Tho H. Ho, Susanna Lintula, Hannu Koistinen, Ulf‐Håkan Stenman, Caj Haglund, Jakob Stenman
Publicado em 2018-02-01